# Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma

> **NCT02334553** · PHASE2 · COMPLETED · sponsor: **SolAeroMed Inc.** · enrollment: 12 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** S1226(8%)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02334553
- **Lead sponsor:** SolAeroMed Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-06
- **Primary completion:** 2015-11-25
- **Final completion:** 2015-11-25
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02334553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02334553, "Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02334553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*